N-{4-[2-chloro-4-(5-propyl-1,2-oxazol-3-yl)phenoxy]-3-hydroxybenzyl}-5-methyl-1,2-oxazole-3-carboxamide

ID: ALA2392449

PubChem CID: 71655161

Max Phase: Preclinical

Molecular Formula: C24H22ClN3O5

Molecular Weight: 467.91

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCc1cc(-c2ccc(Oc3ccc(CNC(=O)c4cc(C)on4)cc3O)c(Cl)c2)no1

Standard InChI:  InChI=1S/C24H22ClN3O5/c1-3-4-17-12-19(27-33-17)16-6-8-22(18(25)11-16)31-23-7-5-15(10-21(23)29)13-26-24(30)20-9-14(2)32-28-20/h5-12,29H,3-4,13H2,1-2H3,(H,26,30)

Standard InChI Key:  AXMZYKSEWGUPCB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
    7.8736   -7.4919    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5899   -7.8923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1702   -7.9045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2850   -7.4715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4621   -7.4999    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9930   -7.8719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7587   -7.9208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1749   -8.7299    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5945   -8.7095    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7634   -8.7380    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0101   -8.6932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2762   -6.6543    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    6.4533   -6.6828    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.4714   -9.1425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3025   -9.1058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6705   -9.1744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6734   -9.9909    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.4503  -10.2443    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9314   -9.5836    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4517   -8.9221    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7486   -9.5844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1564  -10.2926    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9736  -10.2934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0577   -9.1502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3480   -8.7452    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.6429   -9.1569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8787   -8.8673    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6465   -9.9745    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6606   -8.0776    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8443   -8.0383    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5546   -8.8024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1919   -9.3140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7662   -9.0173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  2  0
  6  4  2  0
  7  5  1  0
  8  3  1  0
  9  2  2  0
 10 14  1  0
 11 15  2  0
 12  4  1  0
 13  5  1  0
 14  8  2  0
 15  9  1  0
  7 10  2  0
  6 11  1  0
 11 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 16  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 10 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  2  0
 29 30  1  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 31 33  1  0
M  END

Associated Targets(Human)

HFF (3142 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ENR Enoyl-acyl carrier reductase (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Toxoplasma gondii (4585 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 467.91Molecular Weight (Monoisotopic): 467.1248AlogP: 5.67#Rotatable Bonds: 8
Polar Surface Area: 110.62Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.31CX Basic pKa: 0.62CX LogP: 5.09CX LogD: 5.04
Aromatic Rings: 4Heavy Atoms: 33QED Weighted: 0.34Np Likeness Score: -1.29

References

1. Muench SP, Stec J, Zhou Y, Afanador GA, McPhillie MJ, Hickman MR, Lee PJ, Leed SE, Auschwitz JM, Prigge ST, Rice DW, McLeod R..  (2013)  Development of a triclosan scaffold which allows for adaptations on both the A- and B-ring for transport peptides.,  23  (12): [PMID:23664871] [10.1016/j.bmcl.2013.04.035]

Source